Researchers from Chinese Academy of Sciences detailed the creation of a new dextran sulfate sodium (DSS)-based mouse model of immune checkpoint blockade (ICB) therapy-associated colitis.

They applied yohimbine, an antagonist of ADRA2A, to mice with DSS-induced colitis. Compared with the non-treatment controls, ...

The role of TSP-1 is being investigated by using the dextran sodium sulfate (DSS)-induced colitis in order to recognize its specific molecular targets in colonic inflammation and to design new ...